InvestorsHub Logo
Followers 22
Posts 1086
Boards Moderated 0
Alias Born 10/26/2016

Re: None

Sunday, 12/27/2020 7:16:33 PM

Sunday, December 27, 2020 7:16:33 PM

Post# of 198661
Gilead website as it relates to Covid19: “We are also collaborating with other companies to evaluate combination treatment of Veklury with immune-modulating therapies, with the hope of improving patient outcomes.” After the toxicity results and since they are in the market, Gilead might want to look further into the licensing of ITV-1 for immune-modulating therapies for combination treatment with Veklury.
https://www.gilead.com/purpose/advancing-global-health/covid-19
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ENZC News